Logo image of LIFW

MSP RECOVERY INC (LIFW) Stock Fundamental Analysis

NASDAQ:LIFW - Nasdaq - US5537452097 - Common Stock - Currency: USD

3.24  +1.65 (+103.77%)

After market: 2.73 -0.51 (-15.74%)

Fundamental Rating

1

Overall LIFW gets a fundamental rating of 1 out of 10. We evaluated LIFW against 108 industry peers in the Health Care Providers & Services industry. LIFW may be in some trouble as it scores bad on both profitability and health. LIFW has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LIFW has reported negative net income.
LIFW had a negative operating cash flow in the past year.
LIFW Yearly Net Income VS EBIT VS OCF VS FCFLIFW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -100M -200M -300M -400M -500M

1.2 Ratios

With a Return On Assets value of -3.49%, LIFW perfoms like the industry average, outperforming 44.95% of the companies in the same industry.
LIFW's Return On Equity of -32.40% is on the low side compared to the rest of the industry. LIFW is outperformed by 66.06% of its industry peers.
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROIC N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIFW Yearly ROA, ROE, ROICLIFW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

The Gross Margin of LIFW (66.22%) is better than 88.99% of its industry peers.
In the last couple of years the Gross Margin of LIFW has declined.
The Profit Margin and Operating Margin are not available for LIFW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
LIFW Yearly Profit, Operating, Gross MarginsLIFW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

LIFW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LIFW has less shares outstanding
LIFW has a worse debt/assets ratio than last year.
LIFW Yearly Shares OutstandingLIFW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1B 2B 3B
LIFW Yearly Total Debt VS Total AssetsLIFW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of -1.22, we must say that LIFW is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.22, LIFW is doing worse than 81.65% of the companies in the same industry.
A Debt/Equity ratio of 2.54 is on the high side and indicates that LIFW has dependencies on debt financing.
With a Debt to Equity ratio value of 2.54, LIFW is not doing good in the industry: 77.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Altman-Z -1.22
ROIC/WACCN/A
WACC4.13%
LIFW Yearly LT Debt VS Equity VS FCFLIFW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

LIFW has a Current Ratio of 0.01. This is a bad value and indicates that LIFW is not financially healthy enough and could expect problems in meeting its short term obligations.
LIFW's Current ratio of 0.01 is on the low side compared to the rest of the industry. LIFW is outperformed by 97.25% of its industry peers.
LIFW has a Quick Ratio of 0.01. This is a bad value and indicates that LIFW is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.01, LIFW is not doing good in the industry: 97.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
LIFW Yearly Current Assets VS Current LiabilitesLIFW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

LIFW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1533.49%.
The Revenue has grown by 24.67% in the past year. This is a very strong growth!
LIFW shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -17.83% yearly.
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LIFW Yearly Revenue VS EstimatesLIFW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2B 4B 6B
LIFW Yearly EPS VS EstimatesLIFW Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

LIFW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 0.10, the valuation of LIFW can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIFW indicates a rather cheap valuation: LIFW is cheaper than 100.00% of the companies listed in the same industry.
LIFW's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 0.1
LIFW Price Earnings VS Forward Price EarningsLIFW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIFW Per share dataLIFW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LIFW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MSP RECOVERY INC

NASDAQ:LIFW (12/6/2024, 8:00:02 PM)

After market: 2.73 -0.51 (-15.74%)

3.24

+1.65 (+103.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners47.79%
Inst Owner Change-90.23%
Ins Owners183.4%
Ins Owner Change-8.91%
Market Cap21.25M
Analysts82.86
Price Target3.06 (-5.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.1
P/S 1.98
P/FCF N/A
P/OCF N/A
P/B 0.07
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-101.6
EYN/A
EPS(NY)31.2
Fwd EY963.02%
FCF(TTM)-4.41
FCFYN/A
OCF(TTM)-4.02
OCFYN/A
SpS1.64
BVpS45.78
TBVpS-376.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.49%
ROE -32.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.22%
FCFM N/A
ROA(3y)-11.27%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 2.54
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.53%
Cap/Sales 23.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.22
F-Score3
WACC4.13%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)20.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1533.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.77%
EPS Next Y264.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.67%
Revenue growth 3Y-17.83%
Revenue growth 5YN/A
Sales Q2Q%733.64%
Revenue Next Year203.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.37%
OCF growth 3YN/A
OCF growth 5YN/A